ES421726A1 - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- ES421726A1 ES421726A1 ES421726A ES421726A ES421726A1 ES 421726 A1 ES421726 A1 ES 421726A1 ES 421726 A ES421726 A ES 421726A ES 421726 A ES421726 A ES 421726A ES 421726 A1 ES421726 A1 ES 421726A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- substituted
- choice
- groups
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Procedure for preparing derivatives of 6-substituted-aminopenicyllanic and 7-substituted-aminocephalosporanic acids, with the general formulas **(See formula)** where U represents an amido group (eg saccharyl, succinimido or phthalamido) or a group OE' where E' represents hydrogen, a salt-forming cation, a steric residue such as a (lower) alkyl group substituted by choice with a (lower) alkanoyloxy group which can also be substituted, a silyl group, a phenacyl group, a benzyl group, a benzohydryl group, a trichlorethyl group, or tert-butyl, X represents a hydrogen atom, a hydroxy group, a (lower) alkanoyloxy group (preferably acetoxy) or the residue of a nucleophilic agent, such as a halogen atom, an acid group, a cyano group, and carbamoyloxy group, a choice substituted heterocyclic mononuclear group containing an atom of sulfur or nitrogen (eg pyridinyl); an -S-Q' group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, triatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazol-pyridinyl or puridinyl group), or X represents an amino group where Q represents a group with the formula XX; R1 represents a lower alkyl group (eg methyl, ethyl, propyl, isopropyl, butyl, sec.butyl, isobutyl, t-butyl) optionally substituted in primary or secondary position with 1 fluorine, chlorine atom, a group hydroxy, or lower alkoxy (eg fluoromethyl, 2-chloroethyl, methoxymethyl, 1-hydroxyethyl) or a cycloalkyl group optionally substituted with 1 or more lower alkyl groups, hydroxy or lower alkoxy groups or where R1 represents an adamantyl group or a phenyl group substituted by choice with a maximum of 3 of the substituents selected from chlorine, fluorine, hydroxy, lower alkoxy and lower alkyl, or where it represents a five-membered mononuclear heterocyclic group ( for example, furyl, thienyl, isoxazolyl, isothiazolyl, oxadiazolyl) substituted by choice with lower alkyl groups, or where R1 represents an aralkyl group (for example, benzyl) substituted by choice in the phenyl nucleus as mentioned above, or a carboxymethyl group, and Z1 '' represents, together with the definition indicated above for R1, a hydrogen atom, a (lower) alkyl group optionally substituted with a chlorine or fluorine atom, a (lower) alkoxy group, a cycloalkyl group, a phenyl group, which in turn is substituted by choice with a maximum of three of the aforementioned substituents, or Z1'' represents a carboxy group esterified with a residue of (lower) alkyl, phenyl, cycloalkyl or aralkyl, being at choice said phenyl radicals substituted with a maximum of one of the aforementioned substituents, or Z1'' represents a carbamoyl group N-substituted at choice with one or two lower alkyl groups, a phenyl group, a mononuclear heterocyclic group of five members, one cycloalkyl group, one or two arylalkyl (lower) or cycloalkylalkyl groups (lower being the phenyl and cycloalkyl groups substituted by choice with a maximum of one of the sub above, or Z1'' represents a carbamoyl group having its nitrogen atom as a member of a heterocyclic ring (eg, morpholino) and where R2 represents a group **(See formula)** where n represents 0, 1, 2 or 3, and R3 represents a hydrogen atom or a (lower) alkyl group, and R4 represents a hydrogen atom, a (lower) alkyl, a cycloalkyl, phenyl or aralkyl group, or R4 represents a -COOE group, where E represents a hydrogen atom or a salt-forming group (when n>> 1), or a (lower) alkyl, benzyl or phenyl ester residue, or represents a carbamoyl group N - substituted by choice with one or two (lower) or alkenyl groups, a phenyl group, a cycloalkyl group, one or two arylalkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the aforementioned substituents, or where R3 and R4, together with the carbon atom to which they are attached, represent a substituted cycloalkyl group of choice, and Z4 represents a hydrogen atom or a substituted aryl group of choice which comprises making react a salt, this er or amide of the compound of 6-aminopenicillanic or 7- aminocephalosporic acid of the formulas **(See formula)** where X represents a hydrogen atom, a hydroxy group, a lower alkanoyloxy group (preferably acetoxy) or the residue of a nucleophilic agent, such as a halogen atom, an acid group, a cyano group, a carbamoyloxy group, a Mononuclear heterocyclic group substituted by choice containing a sulfur or nitrogen atom (for example pyridinyl); a -SQ'group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, thiatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazolpyridinyl or purinyl group, optionally substituted) or X represents an amino group when Q represents a group of the formula XX, with the substituent X when it is a hydroxy group or a preferably protected amino group, with an active ester, acid halide, acid anhydride, including a mixed anhydride prepared from stronger acids, acidic acid, active thioester or azolide derived from an acid of the general formula **(See formula)** where (see formula) are as previously defined for R1 and Z1'' or represent groups that can easily become those that fall within the definition of R1 and Z'' and that can be influenced or can react equally under the conditions of reaction used (for example) hydroxy and carboxy protected amino groups) or **(See formula)** where (see formula) are as previously defined for R2 and Z4 or represent groups that can easily become those that fall within the definition of R2 and Z4 or with the acid of formulas XXX or XXXI on their own in the presence of per example a carbodiimide reagent or the like; followed by separation and isolation, or both, of the obtained compound and the removal of the protecting groups present at choice in order to form the corresponding penicilllanic or cephalosporanic acids, and the transformation at choice of these obtained acids into their salts or esters. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5952472A GB1459392A (en) | 1972-12-22 | 1972-12-22 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES421726A1 true ES421726A1 (en) | 1976-04-16 |
Family
ID=10483917
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES421726A Expired ES421726A1 (en) | 1972-12-22 | 1973-12-21 | Heterocyclic compounds |
ES423962A Expired ES423962A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
ES423963A Expired ES423963A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES423962A Expired ES423962A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
ES423963A Expired ES423963A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
Country Status (10)
Country | Link |
---|---|
JP (3) | JPS4994695A (en) |
AT (1) | AT344318B (en) |
BE (1) | BE809037A (en) |
DE (2) | DE2364129A1 (en) |
ES (3) | ES421726A1 (en) |
FR (2) | FR2211232B1 (en) |
GB (1) | GB1459392A (en) |
HU (1) | HU167924B (en) |
NL (2) | NL162654C (en) |
SE (3) | SE7611135L (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905893A (en) * | 1973-08-22 | 1975-09-16 | Gulf Research Development Co | Plural stage residue hydrodesulfurization process |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1364453A (en) * | 1970-11-06 | 1974-08-21 | Gist Brocades Nv | Penicillanic and cepholosporanic acid derivatives |
-
1972
- 1972-12-22 GB GB5952472A patent/GB1459392A/en not_active Expired
-
1973
- 1973-12-19 FR FR7345508A patent/FR2211232B1/fr not_active Expired
- 1973-12-20 NL NL7317432.A patent/NL162654C/en active
- 1973-12-21 JP JP48143379A patent/JPS4994695A/ja active Pending
- 1973-12-21 BE BE139223A patent/BE809037A/en unknown
- 1973-12-21 AT AT1072573A patent/AT344318B/en not_active IP Right Cessation
- 1973-12-21 HU HUGI197A patent/HU167924B/hu unknown
- 1973-12-21 ES ES421726A patent/ES421726A1/en not_active Expired
- 1973-12-21 DE DE2364129A patent/DE2364129A1/en not_active Withdrawn
- 1973-12-21 DE DE2365705A patent/DE2365705A1/en active Pending
-
1974
- 1974-03-06 ES ES423962A patent/ES423962A1/en not_active Expired
- 1974-03-06 ES ES423963A patent/ES423963A1/en not_active Expired
-
1976
- 1976-01-02 FR FR7600026A patent/FR2289171A1/en not_active Withdrawn
- 1976-10-07 SE SE7611135A patent/SE7611135L/en unknown
- 1976-10-07 SE SE7611134A patent/SE7611134L/en unknown
-
1977
- 1977-11-30 JP JP14377477A patent/JPS5373565A/en active Pending
- 1977-11-30 JP JP14377377A patent/JPS5377088A/en active Pending
-
1978
- 1978-06-30 NL NL7807076A patent/NL7807076A/en not_active Application Discontinuation
-
1979
- 1979-07-03 SE SE7905814A patent/SE7905814L/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATA1072573A (en) | 1977-11-15 |
AT344318B (en) | 1978-07-10 |
BE809037A (en) | 1974-06-21 |
DE2365705A1 (en) | 1976-01-15 |
JPS4994695A (en) | 1974-09-09 |
SE7905814L (en) | 1979-07-03 |
FR2289171A1 (en) | 1976-05-28 |
GB1459392A (en) | 1976-12-22 |
NL162654C (en) | 1980-06-16 |
FR2211232B1 (en) | 1978-01-13 |
DE2364129A1 (en) | 1974-07-25 |
NL7807076A (en) | 1978-10-31 |
HU167924B (en) | 1976-01-28 |
NL7317432A (en) | 1974-06-25 |
ES423963A1 (en) | 1976-07-01 |
JPS5373565A (en) | 1978-06-30 |
SE7611135L (en) | 1976-10-07 |
SE7611134L (en) | 1976-10-07 |
NL162654B (en) | 1980-01-15 |
ES423962A1 (en) | 1976-07-01 |
FR2211232A1 (en) | 1974-07-19 |
JPS5377088A (en) | 1978-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8607244A1 (en) | Use of quinoline derivatives for the protection of cultivated plants. | |
PT76316A (en) | Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect | |
NL7505375A (en) | NEW PENICILLIN AND CEPHALOSPORIN DERIVATIVES AND METHOD FOR PREPARING THEM. | |
IE45015L (en) | Cephalosporin derivatives. | |
DK0620225T3 (en) | cephalosporin | |
GB1064252A (en) | Amides and pharmaceutical compositions containing them | |
ES8200685A1 (en) | 3-optionally substituted methyl-2- penem derivatives | |
GB1053085A (en) | ||
GB1459065A (en) | Therapeutic thiophene derivatives | |
GB1505885A (en) | Substituted cephalosporins | |
ES421726A1 (en) | Heterocyclic compounds | |
ES479570A1 (en) | 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity | |
IE41219L (en) | Aralkyl esters of aminoalkanoic acids | |
ES478387A1 (en) | Beta-lactam compounds, process for their preparation and their use in medicines. | |
ATE123487T1 (en) | DERIVATIVES OF CAFEIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES469182A1 (en) | Antibacterial agents | |
JPS5246093A (en) | 2-alkyl-7-substituted-2, or 3-cephem-4-carboxylic compounds, their sal ts, and preparation thereof | |
GB1321407A (en) | 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic acid esters | |
ES484115A1 (en) | Aurone derivatives | |
ZA857945B (en) | 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them | |
JPS54106495A (en) | Cephem derivative | |
GB1410852A (en) | Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them | |
AU4878479A (en) | Clavulanic acid derivatives | |
ES430905A1 (en) | Tetrazole coumarin derivatives | |
KR850000456A (en) | Process for preparing cephalosporin ester |